Can a woman with a prior low‑transverse (lower segment) cesarean section safely attempt a trial of labor after cesarean (VBAC), and what are the eligibility criteria and management recommendations?

Trial of Labor After Cesarean (TOLAC) for Women with Prior Low-Transverse Cesarean Section

Women with one prior low-transverse cesarean section should be offered a trial of labor after cesarean (TOLAC) as a safe and practical option after thorough counseling about risks and benefits. 1

Eligibility Criteria

Candidates Appropriate for TOLAC

• Most women with 1–2 prior low-transverse cesarean deliveries are suitable candidates for TOLAC and should receive guidance and encouragement about vaginal birth after cesarean (VBAC). 1

• Previous vaginal delivery—especially a prior successful VBAC—is the strongest predictor of TOLAC success, with approximately 74% of U.S. women achieving vaginal birth during TOLAC. 1

• Spontaneous onset of labor is strongly preferred over induction, as it carries lower uterine rupture risk. 2

• An interpregnancy interval ≥18 months is a favorable factor for successful TOLAC and reduced rupture risk. 2

Absolute Contraindications to TOLAC

• A classic (vertical) uterine scar from prior cesarean is an absolute contraindication to TOLAC due to prohibitively high rupture risk. 2

• Placenta previa covering the cervical os requires cesarean delivery and precludes TOLAC. 2

Relative Contraindications and Risk Factors

• Interpregnancy intervals <18 months significantly increase uterine rupture risk and require intensive counseling; women with intervals ≤6.5 months should be counseled toward repeat cesarean. 2

• Fetal macrosomia (estimated weight ≥4 kg) decreases VBAC likelihood but does not constitute an absolute contraindication. 1, 2

• Multiple gestation, diabetes mellitus, and postdates pregnancy are NOT contraindications to TOLAC. 3, 4

Labor Induction and Augmentation: Critical Safety Considerations

Induction Method Selection and Uterine Rupture Rates

The choice of induction agent dramatically affects uterine rupture risk:

• Misoprostol is absolutely contraindicated in women with prior cesarean, carrying a 13% rupture rate. 1, 2

• Prostaglandin E₂ (dinoprostone) should be avoided except in rare circumstances after extensive counseling, with a 2% rupture rate (95% CI 1.1–3.5%). 1, 2

• Oxytocin may be used cautiously for both augmentation and induction, with a 1.1% rupture rate (95% CI 0.9–1.5%). 1, 2

• Foley catheter for cervical ripening is considered safe, with no reported ruptures. 1, 2

Intrapartum Management

• Continuous electronic fetal monitoring is mandatory during TOLAC to detect early signs of uterine rupture. 3, 4

• Higher Bishop scores and greater labor progression increase VBAC likelihood, while oxytocin induction decreases success rates. 1

• Physicians should reassess the labor plan when patients present in labor, considering factors that affect rupture risk and vaginal delivery success. 1

Management of Suspected Uterine Rupture

When uterine rupture is suspected, urgent laparotomy must be performed within 18 minutes to optimize maternal and neonatal outcomes. 2

• Neonates delivered ≤18 minutes after rupture typically have normal umbilical pH and Apgar scores. 2

• Delivery >30 minutes after rupture is associated with significantly worse long-term neonatal outcomes. 2

• A 30-minute decision-to-incision interval should be the institutional standard for emergency cesarean capability. 3, 4

Facility Requirements and Safety Infrastructure

TOLAC should only be offered in hospitals where timely cesarean section is available, with immediate access to obstetric, anesthetic, pediatric, and operating room staff. 3, 4

• Each hospital must have written policies regarding physician notification and consultation for urgent cesarean delivery. 3, 4

• If VBAC is not available at a facility, patients should be referred to centers that can provide it. 1

Counseling Framework: Balancing Short-Term and Long-Term Outcomes

Short-Term Maternal Outcomes

Short-term maternal outcomes are as good or better with TOLAC/VBAC compared to repeat cesarean delivery, though perinatal mortality is slightly higher. 1

• Maternal mortality risk is lower with TOLAC compared to repeat cesarean. 1

• The absolute risk of uterine rupture during TOLAC is low but represents the most feared complication. 5

Long-Term Maternal Risks of Repeat Cesarean

Repeat cesarean delivery progressively increases long-term risks that must be weighed against TOLAC risks:

• Placenta previa incidence rises with each cesarean: ~9/1,000 after one, 17/1,000 after two, and 30/1,000 after three or more. 2

• Abnormal placentation (accreta spectrum) risk escalates with each additional cesarean. 2

• Hysterectomy risk increases progressively with the number of prior cesarean deliveries. 1, 2

Patient-Centered Decision Making

Counseling should occur at early prenatal visits, incorporating each patient's risk factors, values, preferences, and future childbearing plans. 1

• Predictive scoring models have limited clinical value and cannot reliably identify which women will require cesarean during TOLAC. 1

• The process of informed consent with appropriate documentation should be a central component of the birth plan. 3, 4

Critical Pitfalls to Avoid

• Never use misoprostol in any woman with a prior cesarean—the 13% rupture rate makes this absolutely contraindicated. 1, 2

• Never delay laparotomy beyond 18–30 minutes when uterine rupture is suspected. 2

• Never overlook short interpregnancy intervals (<18 months) during TOLAC counseling, as they substantially heighten rupture risk. 2

• Never attempt TOLAC without continuous electronic fetal monitoring and immediate cesarean capability. 3, 4